Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11127699 | chr3:80551354 | G/A | 2.79E-5 | 178 | 19.53 | 24.53 | 27.2 | KM Plot |
PCPG | rs111305290 | chr7:158671423 | G/C | 0 | 175 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs111314343 | chr9:86492810 | T/C | 0.000126 | 175 | 26.57 | 24.7 | 14.47 | KM Plot |
PCPG | rs111331364 | chr18:44153339 | G/A | 1.24E-7 | 174 | 25.08 | 27.2 | 19.87 | KM Plot |
PCPG | rs111353348 | chr3:129052507 | T/TTAAA | 9.52E-5 | 176 | 25.17 | 27.93 | 19.87 | KM Plot |
PCPG | rs111403728 | chr13:114163627 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs111480316 | chr20:6003219 | A/G | 0 | 178 | 25.67 | 23.08 | 2.93 | KM Plot |
PCPG | rs111494372 | chr14:74436418 | T/TAATA | 3.34E-6 | 177 | 25.4 | 28.47 | 10.3 | KM Plot |
PCPG | rs111516966 | chr12:124035781 | G/A | 0.000484 | 172 | 25.87 | 19.2 | 20.13 | KM Plot |
PCPG | rs111567050 | chr11:18159938 | T/C | 4.95E-6 | 174 | 26.53 | 23.48 | 8.33 | KM Plot |
PCPG | rs111571503 | chr14:74288430 | A/G | 1.15E-5 | 174 | 25.87 | 26.57 | 10.43 | KM Plot |
PCPG | rs111580405 | chr12:56739557 | A/G | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs11159056 | chr14:74473607 | T/C | 4.64E-7 | 174 | 25.17 | 30.93 | 7.4 | KM Plot |
PCPG | rs11159059 | chr14:74502495 | C/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs11159060 | chr14:74503859 | G/T | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |